Last reviewed · How we verify

NCT06551025

Comparison of Clinical Parameters in Individuals With Different Physical Activity Levels During the COVID-19 Pandemic Period

Completed Last updated 13 August 2024
What this trial tests

trial in Physical Activity in 64 participants. Completed in 30 August 2021.

Timeline
27 March 2021
Primary endpoint
30 August 2021
30 August 2021

Quick facts

Lead sponsorHacettepe University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment64
Start date27 March 2021
Primary completion30 August 2021
Estimated completion30 August 2021
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Hacettepe University

Who can join

Adults 18 to 65, any sex, with Physical Activity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The COVID-19 pandemic started in China towards the end of 2019 and soon affected the whole world. Restriction and isolation measures have been taken to prevent the spread of this disease caused by a new type of coronavirus, coronavirus-2. These measures have changed people's physical activity levels and have also affected other parameters that physical activity affects. This study aims comparison of clinical parameters in with different physical activity levels during the COVID-19 pandemic period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Physical Activity

Currently open trials in the same condition.

Other Hacettepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06551025.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing